Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1.50 break and this will run...
Thank u who ever u are...
Tim sykes tweet today...SCARY as shyt..
Either we run big or we tank to hell...
“profit.ly/500NlI - Posted a New Webinar: Challenge Webinar 7-5 [On Demand] $FCEL $SLS”
Change of scenery...Lush GREEN...
Pardon the rookie...LMAO
Its about to run...Been upticking for the last couple of days.
Bulls out of the corral..bottom in.
Should be green EOD.
16 bottom? Big support waiting and never get filled...
Wrong board
LoL
LoL kidding right?
There is a reason there are so called MM to bring that up more than the warrant price to make money....
Kiss of down ward trend showed up.
I really hate to say this but Shorts will take it down close to .10 as there is no conversion rate for the pref C and D. Sucks but it is what it is.
Avg down is in place here.
We will see tomorrow on which direction they will take FCEL.
1.55 resistance.
Break that and will run away!
Not really lmao
Watch the pps jump up once the MM game is over.
They are trading to themselves between 0005 to 0001....
MOAS cometh....
“Tenax Therapeutics Inc (NASDAQ:TENX) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 301,900 shares, a decline of 59.9% from the April 30th total of 752,400 shares. Based on an average daily volume of 520,200 shares, the short-interest ratio is presently 0.6 days. Approximately 26.0% of the company’s stock are short sold.”
GNCC Capital, Inc. (OTC: GNCP) ("The Company" or "GNCC") confirms that they complied with the new OTC Disclosure Rules and filed each and every outstanding Annual and Quarterly Report complete with the "Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines". A total of 18 Reports and two Attorney Letters were filed due to additional information requested by the OTC Markets Compliance Division following their review. These Financial Reports are available for review on the OTC Markets web site. These Reports commenced from the Annual Report to September 30, 2015 and up to and including the Second Quarter to March 31, 2019.
The Company was restored last week to that of "PINK CURRENT" on the OTC Markets.
Following the Company regaining its status on the OTC Markets, the due diligence and negotiations in respect of certain transactions under consideration were immediately re-commenced. To that end, the Company reasonably expects to provide further details without any further delays. These transactions are solely in the Hemp and Cannabis Sectors. Shareholders should appreciate that your Company's Directors are conducting far more exhaustive due diligence than is usual. This is to not only protect the Company; but its Directors and our shareholders.
We will go so far as to state as follows: That in the prevailing "Wild West" environment currently flourishing in both the Cannabis and Hemp Sectors, there are many unscrupulous "bad actors" whom attempt to inundate Public Company Management with transactions and to then deliberately misrepresent facts in an attempt to convince the Directors of Companies of the merits of such deals being brokered by themselves. Companies such as ourselves are prime targets for these predators. Those whom prey in this current climate do so solely for their own exclusive benefit and if they remain unchecked; are a very serious threat to any Company, its Directors and indeed, to shareholders.
This is the primary reason for your Company's Directors being extremely vigilant in their due diligence. This being in respect of each and every transaction being brought to the Company. Your current Directors intend to continue to serve shareholders until such time as the best possible outcome is achieved in respect of the Company's Mining Exploration Interests. They will continue to honor their fiduciary duties to the best of their abilities in respect of all transactions of whatsoever nature; and very particularly in any of the proposed Cannabis and Hemp Sector transactions.
We can now confirm that an external advisor is examining the prospect of the Company embarking upon what would be a large project with immediate significant revenues and cash flow. The Project is retail related and includes "value added" Hemp based products. This will require significant financing if we elect to proceed. Such financing would be through commercial loans secured over this Project's assets as well as the use of other conventional financing methods. No shares of the Company's Common nor the Preferred Stock would be issued whatsoever to secure anything whatsoever; this pertaining to both this Project and the financing thereof.
However, our advisers have presented us with an extremely valid and very possible workable restructuring proposal which would address and deal with a number of issues including but not limited to our Mining Exploration Assets, the Preferred Stock structure and our shareholder concerns in respect of potential Preferred Stock conversions and subsequent dilution.
This, if enacted, will result in very material events being implemented and in fairly short order.
In the interim, it is business as usual as we continue to review and evaluate the options that relate to this restructuring proposal.
No restructuring plans nor any corporate actions will result in a Reverse Split of our Common Stock as we view that as toxic and not in our shareholders' interests.
The Company's Directors also want to take this opportunity to remind our shareholders that our accounting policy for years was not to capitalize any value of our Mining Exploration Interests on our Balance Sheet and always took full Impairment Charges. Therefore speculation as to our valuation in respect of the value of these interests is pointless pending guidance from ourselves.
The Company will be providing an update that relates to specific issues raised by our shareholders; insofar as they are unrelated to our potential acquisitions, transactions and as to the proposed restructuring.
We will continue to now provide further updates to our shareholders as material events warrant further disclosure.
Inching higher everyday towards the PT
Chart shaping up sweetly....
History runs TENX fast.
Phase 3 no doubt coming. Conditional approval in australia and new zealand have been met.
Been green for 2 days on heavy accumulation. Something BIG is coming?
Squeeze or fast trak ?
Darn this poster is annoying!
Keeps on repeating “itSelf”...
Phase 3 on its way.....
Chart scream for 1.18 bottom.
Avg down is in place.
Still holding and waiting for that high 6 figure profit.
PT is 10 above....see analyst review.
Chart is in accumulation mode. Bought me a bunch yesterday at avg pps of 5.15
This is a no brainer with PT of 8 bucks and above.
See analyst review......
End of June...accumulation going on as time goes by.
PT is 6 and above if fda will green light the new drug investigation.
Was wondering if BK is going to happen?
If they do, will play this on dip financing under 5c.
5.50? Yikes...thats too far off from the closing price today.
Mmmmmm
2019 coming according to the latest tweet.
Stop to yield in a couple of days!
2018 filings now! Bring it on!!!
AS OS reduce is on the horizon
2017 filings out. Once all filings done and current achieved....
AS/OS reduction next!
LoL have u been dreamin? What flood? Not even a drop of rain happened for months...
NIO is 1B shares out?
Hoping NIO will not be hard affected by the tariff/trade war.
Metals will be slap 25% if the trade war will continue.
Filing started. We should be out of tripz perty soon!
Why the sudden surge of volume today? Ask really got thin?
Yes we do
Are we there yet?
Dude its already Wednesday.
Just sit back and relax!
A company of 'firsts', YCBD is not only first to the NYSE American, they were the first to advertise in Times Square and the first to advertise in Rolling Stone and ELLE magazines. This ticker represents cbdMD as the consistent leader and innovator in this booming market.
$6.25 After Hours. Ticker change to #YCBD and to present @ThinkEquity in 2 days.